Quarterly Result16 Feb 2026, 07:23 pm
Star Source Multi Trade Ltd Approves Q3 and Nine Months Results for 2025
AI Summary
Star Source Multi Trade Ltd, formerly known as Chemo Pharma Laboratories Limited, held a Board Meeting on February 12, 2026, at 12:00 PM and concluded at 12:45 PM. The Board approved and considered the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025. The Limited Review Report for the quarter ended on December 31, 2025, was also reviewed and approved. The company's revenue from operations for the nine months ended on December 31, 2025, was 5,256.56 thousand rupees, with a net profit of 6818.00 thousand rupees.
Key Highlights
- Star Source Multi Trade Ltd approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025.
- The Limited Review Report for Q3 2025 was also approved.
- Revenue from operations for the nine months ended on December 31, 2025, was 5,256.56 thousand rupees.
- The net profit for the nine months ended on December 31, 2025, was 6818.00 thousand rupees.
- The Board Meeting was held on February 12, 2026, and concluded at 12:45 PM.
Price Impact
More from CHEMOPH